Ogast (Lansoprazole)

Lansoprazole belongs to the proton pump inhibitor class. It binds covalently to the H+/K+‑ATPase enzyme on the secretory surface of gastric parietal cells, irreversibly blocking the final step of acid production. This inhibition lowers both basal and stimulated gastric acidity, providing a sustained reduction in stomach acid levels.

The specific dose of Ogast is determined by the prescribing healthcare professional based on the patient’s condition, severity, and response to therapy. Dosage may vary for short‑term versus long‑term treatment, and the prescriber will provide individualized instructions.

Lansoprazole is classified as Pregnancy Category B in many regions, indicating no evidence of risk in animal studies but insufficient human data. It should only be used during pregnancy or lactation if clearly needed and after a risk‑benefit assessment by the prescriber. Breastfeeding mothers should discuss potential exposure with their healthcare provider.

To request Ogast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ogast (Lansoprazole) shares the same mechanism of action as other PPIs such as omeprazole, esomeprazole and pantoprazole, providing comparable acid suppression. Differences may lie in pharmacokinetic profiles, drug‑interaction potential, and individual patient tolerance. Choice of PPI often depends on clinician preference, patient response, and specific drug‑interaction considerations.

Ogast tablets should be stored at temperatures below 25 °C (77 °F). Keep them in the original packaging to protect from moisture and light, and store in a dry place away from direct heat. Do not refrigerate or freeze the product.

Ogast tablets are taken orally, usually once daily before a meal, preferably in the morning. The tablet should be swallowed whole with a glass of water and not crushed or chewed, unless otherwise directed by the prescriber.

Serious risks, though uncommon, include Clostridioides difficile‑associated diarrhea, severe allergic reactions such as anaphylaxis, hepatic injury, hypomagnesemia with long‑term use, and rare skin reactions like Stevens‑Johnson syndrome. Patients should be advised to seek immediate medical attention if they experience severe rash, persistent diarrhea, jaundice, or muscle weakness.

Patients with known hypersensitivity to Lansoprazole or any component of the tablet should not use Ogast. Caution is advised for individuals with severe liver disease, those taking medications that have major interactions (e.g., clopidogrel), and patients with a history of osteoporosis or fractures when considering long‑term therapy.